BIO KEY INTERNATIONAL INC - 8-K Filing
On July 7, 2026, BIO-key International announced that trading of its common stock (BKYI) will resume on the Nasdaq Capital Market effective July 8, 2026. The reinstatement followed a hearing with a Nasdaq Hearings Panel which determined the company has regained compliance with listing standards including minimum bid price and SEC filing requirements. The company is subject to monitoring for one year until July 6, 2027. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $BKYI